The story of Viagra, initially marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical landscape . Although its early success and creation of vast in sales, the patent lapse has opened the floodgates for competing medications, substantially eroding earnings opportunities. This shift raises doubts about th